Analysis of the interplay between methylation and expression reveals its potential role in cancer aetiology.
With ongoing developments in technology, changes in DNA methylation levels have become prevalent to study cancer biology. Previous studies report that DNA methylation affects gene expression in a direct manner, most probably by blocking gene regulatory regions. In this study, we have studied the interplay between methylation and expression to improve our knowledge of cancer aetiology. For this purpose, we have investigated which genomic regions are of higher importance; hence, first exon, 5'UTR and 200 bp near the transcription start sites are proposed as being more crucial compared to other genomic regions. Furthermore, we have searched for a valid methylation level change threshold, and as a result, 25 % methylation change in previously determined genomic regions showed the highest inverse correlation with expression data. As a final step, we have examined the commonly affected genes and pathways by integrating methylation and expression information. Remarkably, the GPR115 gene and ErbB signalling pathway were found to be significantly altered for all cancer types in our analysis. Overall, combining methylation and expression information and identifying commonly affected genes and pathways in a variety of cancer types revealed new insights of cancer disease mechanisms. Moreover, compared to previous methylation-based studies, we have identified more important genomic regions and have defined a methylation change threshold level in order to obtain more reliable results. In addition to the novel analysis framework that involves the analysis of four different cancer types, our study exposes essential information regarding the contribution of methylation changes and its impact on cancer disease biology, which may facilitate the identification of new drug targets.
Advanced Genomics and Bioinformatics Research Center (IGBAM), The Scientific and Technological Research Council of Turkey (TUBITAK), 41470, Gebze, Kocaeli, Turkey. bugraozer@sabanciuniv.edu.|Biological Sciences and Bioengineering Program, Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul, Turkey. bugraozer@sabanciuniv.edu.
Bugra
http://orcid.org/0000-0002-1441-4162
B
Ozer
Department of Biostatistics and Medical Informatics, Acibadem University, Istanbul, Turkey.|Biological Sciences and Bioengineering Program, Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul, Turkey.
Ugur
U
Sezerman
D019175:DNA Methylation / Q000235:genetics*; D044127:Epigenesis, Genetic; D066246:ErbB Receptors / Q000096:biosynthesis / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D011401:Promoter Regions, Genetic; D043562:Receptors, G-Protein-Coupled / Q000096:biosynthesis / Q000235:genetics; D015398:Signal Transduction / Q000235:genetics; D024363:Transcription Initiation Site
C516038:ADGRF5 protein, human; D043562:Receptors, G-Protein-Coupled; C512478:EGFR protein, human; D066246:ErbB Receptors
Bioinformatics; Cancer biology; Data integration; Expression; Functional enrichment analysis; Integrative analysis; Methylation